On May 27, Health 160 (02656.HK) fell 5.55% in regular trading, trading at 15.63 HKD/share, with trading volume of 32.22 million HKD. The stock has now declined for two consecutive sessions, following a 5.03% drop in the prior trading day.

Within the Health Care Distributors sector where Health 160 belongs, the overall sector performance is mixed. Among individual stocks, SINOPHARM down 1.61%, SH PHARMA down 0.87%, YSB up 1.14%, BAIYUNSHAN PH down 0.06%, GUANZE MEDICAL up 2.38%.

Health 160 International Limited is an investment holding company principally engaged in pharmaceutical sales. The company operates through two main segments: pharmaceutical and health product sales via wholesale and retail models, and digital healthcare solutions including online marketing solutions, digital hospital solutions, and online health services. The company operates the Health 160 platform and primarily conducts business in mainland China.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)